FPR2 (lipoxin A4 receptor) agonist. Suppresses tumor-related angiogenesis and reduces tumor growth in hepatoma H22 cell bearing mice. Also protects against hemorrhagic shock-induced acute lung injury in rats. Lipoxin A4 analog.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 192.21. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||5.2 mL||26.01 mL||52.03 mL|
|5 mM||1.04 mL||5.2 mL||10.41 mL|
|10 mM||0.52 mL||2.6 mL||5.2 mL|
|50 mM||0.1 mL||0.52 mL||1.04 mL|
The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.
References are publications that support the products' biological activity.
Chen et al (2010) Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis. Mol.Cancer.Ther. 9 2164 PMID: 20682645
Gong et al (2012) BML-111, a lipoxin receptor agonist, protects haemorrhagic shock-induced acute lung injury in rats. Resuscitation. 83 907 PMID: 22245750
If you know of a relevant reference for BML 111, please let us know.
View Related Products by Product Action
Keywords: BML 111, supplier, BML111, formyl, peptide, receptors, FPR2, agonists, agonism, lipoxinA4, LPA4, Formyl, Peptide, Receptors, Tocris Bioscience
Citations for BML 111
Citations are publications that use Tocris products.
Currently there are no citations for BML 111. Do you know of a great paper that uses BML 111 from Tocris? If so please let us know.